Brent Warner

Insider Reports History

Location
San Diego, CA
Signature
/s/ Harry J.Leonhardt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brent Warner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Poseida Therapeutics, Inc. President, Gene Therapy Common Stock 419,040 $1,730,635 $4.13 01 Mar 2024 Direct
Poseida Therapeutics, Inc. President, Gene Therapy Employee Stock Option (Right to Buy) 111,700 01 Mar 2024 Direct

Insider Reports Filed by Brent Warner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024024920-warner-brent-2024-03-01 Poseida Therapeutics, Inc. 01 Mar 2024 3 -$147,602 4 President, Gene Therapy 04 Mar 2024, 17:18
/report/000120919123014910-warner-brent-2023-03-01 Poseida Therapeutics, Inc. 01 Mar 2023 3 -$142,401 4 President, Gene Therapy 02 Mar 2023, 17:30
/report/000120919122014372-warner-brent-2022-03-01 Poseida Therapeutics, Inc. 01 Mar 2022 2 $0 4 President, Gene Therapy 01 Mar 2022, 18:27
/report/000120919122014371-warner-brent-2022-02-21 Poseida Therapeutics, Inc. 21 Feb 2022 0 $0 3 President, Gene Therapy 01 Mar 2022, 18:26